August 2023 in “Sabuncuoglu Serefeddin Health Sciences” This study investigated the role of CTLA4 CT60 A/G and +49AG polymorphisms in susceptibility to Alopecia Areata (AA) in a Turkish population. It included 195 patients and 173 healthy controls, with genotype and allele frequencies determined by PCR-RFLP method. The results indicated that the +49AG polymorphism was not associated with AA susceptibility, but the CT60 polymorphism might be associated with increased susceptibility to AA. Further studies are needed to confirm these findings.
34 citations,
December 2017 in “Archivos Argentinos De Pediatria” Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.
144 citations,
July 2015 in “Clinical, Cosmetic and Investigational Dermatology” Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.
82 citations,
March 2016 in “Autoimmunity reviews” Animal models have helped understand hair loss from alopecia areata and find new treatments.
9 citations,
December 2017 in “The Journal of Allergy and Clinical Immunology” New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.